Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.

Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedNew revision v3.6.3 has been added to the study's record history, replacing v3.6.2. This indicates an update to the page history rather than substantive changes to trial data.SummaryDifference0.1%

- Check12 days agoChange DetectedThe study record status is updated to Completed with no longer looking for participants, and new sections for Contacts/Locations, Study Design, Study Status, and Recruitment Status are added. At the same time, recruitment-related links such as Check who can join, Recruiting, and Find Contact Information are removed, changing how viewers access trial details and contact info.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedTwo new navigation items, 'Check who can join' and 'Find Contact Information', were added to the page. The release notes show a new version, Revision: v3.6.0, and the previous Revision: v3.5.5 entry was removed.SummaryDifference0.5%

- Check33 days agoChange DetectedA new revision entry (v3.5.5) was added to the study record history, and the previous revision (v3.5.4) was removed from the visible list, reflecting an update to the record's version history.SummaryDifference0.1%

- Check55 days agoChange DetectedThe revision label in the page footer was updated from v3.5.3 to v3.5.4, indicating a new version of the study record history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe revision in the record history advances from v3.5.2 to v3.5.3, representing a minor update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.